SwePub
Sök i LIBRIS databas

  Utökad sökning

(WFRF:(Verhey Frans)) pers:(Engelborghs Sebastiaan)
 

Sökning: (WFRF:(Verhey Frans)) pers:(Engelborghs Sebastiaan) > (2017) > The frequency and i...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00012637naa a2201165 4500
001oai:DiVA.org:oru-74047
003SwePub
008190507s2017 | |||||||||||000 ||eng|
009oai:prod.swepub.kib.ki.se:136232937
009oai:lup.lub.lu.se:f9eda6d8-d679-4d81-b560-6c3801a70540
009oai:gup.ub.gu.se/254306
024a https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-740472 URI
024a https://doi.org/10.1016/j.neurobiolaging.2017.03.0342 DOI
024a http://kipublications.ki.se/Default.aspx?queryparsed=id:1362329372 URI
024a https://lup.lub.lu.se/record/f9eda6d8-d679-4d81-b560-6c3801a705402 URI
024a https://gup.ub.gu.se/publication/2543062 URI
040 a (SwePub)orud (SwePub)kid (SwePub)lud (SwePub)gu
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Bos, Isabelleu Department of Psychiatry and Neuropsychology, Maastricht University, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht, Netherlands4 aut
2451 0a The frequency and influence of dementia risk factors in prodromal Alzheimer's disease
264 1b Elsevier,c 2017
338 a print2 rdacarrier
520 a We investigated whether dementia risk factors were associated with prodromal Alzheimer's disease (AD) according to the International Working Group-2 and National Institute of Aging-Alzheimer's Association criteria, and with cognitive decline. A total of 1394 subjects with mild cognitive impairment from 14 different studies were classified according to these research criteria, based on cognitive performance and biomarkers. We compared the frequency of 10 risk factors between the subgroups, and used Cox-regression to examine the effect of risk factors on cognitive decline. Depression, obesity, and hypercholesterolemia occurred more often in individuals with low-AD-likelihood, compared with those with a high-AD-likelihood. Only alcohol use increased the risk of cognitive decline, regardless of AD pathology. These results suggest that traditional risk factors for AD are not associated with prodromal AD or with progression to dementia, among subjects with mild cognitive impairment. Future studies should validate these findings and determine whether risk factors might be of influence at an earlier stage (i.e., preclinical) of AD.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Neurologi0 (SwePub)302072 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Neurology0 (SwePub)302072 hsv//eng
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Geriatrik0 (SwePub)302222 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Geriatrics0 (SwePub)302222 hsv//eng
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Psykiatri0 (SwePub)302152 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Psychiatry0 (SwePub)302152 hsv//eng
650 7a MEDICIN OCH HÄLSOVETENSKAPx Medicinska och farmaceutiska grundvetenskaperx Neurovetenskaper0 (SwePub)301052 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Basic Medicinex Neurosciences0 (SwePub)301052 hsv//eng
653 a Alzheimer's disease
653 a Biomarkers
653 a IWG-2 criteria
653 a NIA-AA criteria
653 a Prognosis
653 a Risk factors
653 a Alzheimer's disease
653 a Biomarkers
653 a IWG-2 criteria
653 a NIA-AA criteria
653 a Prognosis
653 a Risk factors
700a Vos, Stephanie J.u Department of Psychiatry and Neuropsychology, Maastricht University, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht, Netherlands4 aut
700a Frölich, Lutzu Department of Geriatric Psychiatry, Zentralinstitut für Seelische Gesundheit, University of Heidelberg, Mannheim, Germany4 aut
700a Kornhuber, Johannesu Department of Psychiatry and Psychotherapy, Friedrich-Alexander University of Erlangen-Nürnberg, Erlangen, Germany4 aut
700a Wiltfang, Jensu Department of Psychiatry and Psychotherapy, University Medical Center (UMC), Georg-August-University, Göttingen, Germany4 aut
700a Maier, Wolfgangu Department of Psychiatry and Psychotherapy, University of Bonn, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany4 aut
700a Peters, Oliveru Department of Psychiatry and Psychotherapy, Charité Berlin, Berlin, Germany,Charité - University Medicine Berlin4 aut
700a Rüther, Eckhartu Department of Psychiatry and Psychotherapy, University of Göttingen, Göttingen, Germany4 aut
700a Engelborghs, Sebastiaanu Department of Neurology and Memory Clinic, Hospital Network Antwerp (ZNA) Middelheim and Hoge Beuken, Antwerp, Belgium; Reference Center for Biological Markers of Dementia (BIODEM), University of Antwerp, Antwerp, Belgium4 aut
700a Niemantsverdriet, Ellisu Reference Center for Biological Markers of Dementia (BIODEM), University of Antwerp, Antwerp, Belgium4 aut
700a De Roeck, Ellen Elisau Reference Center for Biological Markers of Dementia (BIODEM), University of Antwerp, Antwerp, Belgium; Department of Clinical and Lifespan Psychology, Vrije Universiteit Brussel, Brussels, Belgium,Vrije Universiteit Brussel (VUB)4 aut
700a Tsolaki, Magdau 3rd Department of Neurology, Aristotle University of Thessaloniki, Memory and Dementia Center, “G Papanicolau” General Hospital, Thessaloniki, Greece4 aut
700a Freund-Levi, Yvonne,d 1956-u Karolinska Institute,Karolinska University Hospital4 aut0 (Swepub:oru)yfi
700a Johannsen, Peteru Danish Dementia Research Centre, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark4 aut
700a Vandenberghe, Riku Department of Neurology, University of Hospital Leuven, Leuven, Belgium; Laboratory for Cognitive Neurology, Department of Neurosciences, KU Leuven, Belgium,Catholic University of Leuven4 aut
700a Lleó, Albertou Hospital de la Santa Creu i Sant Pau, Barcelona, Spain4 aut
700a Alcolea, Danielu Hospital de la Santa Creu i Sant Pau, Barcelona, Spain4 aut
700a Frisoni, Giovanni B.u Geneva Neuroscience Center, University Hospital and University of Geneva, Geneva, Switzerland; IRCCS San Giovanni di Dio Fatebenefratelli, Brescia, Italy4 aut
700a Galluzzi, Samanthau IRCCS San Giovanni di Dio Fatebenefratelli, Brescia, Italy,Centro San Giovanni di Dio Fatebenefratelli4 aut
700a Nobili, Flaviou Clinical Neurology, Department of Neurosciences (DINOGMI), University of Genoa and IRCCS AOU San Martino-IST, Genoa, Italy,Ospedale Policlinico San Martino4 aut
700a Morbelli, Silviau Nuclear Medicine, Department of Health Science (DISSAL), University of Genoa IRCCS AOU San Martino-IST, Genoa, Italy,Ospedale Policlinico San Martino4 aut
700a Drzezga, Alexanderu Department of Nuclear Medicine, University of Cologne, Cologne, Germany4 aut
700a Didic, Mirau AP-HM Hôpitaux de la Timone, Service de Neurologie et Neuropsychologie, Marseille, France; Aix-Marseille Université, INSERM, Institut de Neurosciences des Systèmes, Marseille, France,La Timone University Hospital4 aut
700a van Berckel, Bart N.u Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, the Netherlands,Amsterdam UMC - Vrije Universiteit Amsterdam4 aut
700a Salmon, Ericu Department of Neurology and Memory Clinic, CHU Liège, Liège, Belgium; GIGA-CRC in vivo Imaging, University of Liège, Liège, Belgium,University of Liège Hospital4 aut
700a Bastin, Christineu GIGA-CRC in vivo Imaging, University of Liège, Liège, Belgium4 aut
700a Dauby, Soleneu Department of Neurology and Memory Clinic, CHU Liège, Liège, Belgium,University of Liège Hospital4 aut
700a Santana, Isabelu Department of Neurology and Memory Clinic, CHU Liège, Liège, Belgium,University of Liège Hospital4 aut
700a Baldeiras, Inêsu Center for Neuroscience and Cell Biology, Faculty of Medicine, Department of Neurology, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal,University Hospital of Coimbra4 aut
700a de Mendonça, Alexandreu Institute of Molecular Medicine and Faculty of Medicine, University of Lisbon, Portugal4 aut
700a Silva, Dinau Institute of Molecular Medicine and Faculty of Medicine, University of Lisbon, Portugal4 aut
700a Wallin, Anders,d 1950u Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi,Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry4 aut0 (Swepub:gu)xwaand
700a Nordlund, Arto,d 1962u Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi,Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry4 aut0 (Swepub:gu)xnorar
700a Coloma, Preciosa M.u Real World Data Science (RWD-S) Neuroscience and Established Products, F. Hoffmann-La Roche Ltd. Pharmaceuticals Division, Basel, Switzerland4 aut
700a Wientzek, Angelikau PDB RWD (Real World Data) Team, Roche Products Limited, Welwyn Garden City, UK; Epidemiologische Beratung und Literatur-Recherche “conepi”, Herrsching, Germany4 aut
700a Alexander, Myriamu PDB RWD (Real World Data) Team, Roche Products Limited, Welwyn Garden City, UK4 aut
700a Novak, Gerald P.u Janssen Pharmaceutical Research and Development, Titusville, NJ, USA4 aut
700a Gordon, Mark Forrestu Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, CT, USA4 aut
700a Wallin, Åsa K.u Lund University,Lunds universitet,Klinisk minnesforskning,Forskargrupper vid Lunds universitet,Clinical Memory Research,Lund University Research Groups4 aut0 (Swepub:lu)med-was
700a Hampel, Haraldu Sorbonne Universités, Université Pierre et Marie Curie, Paris 06, AXA Research Fund & UPMC Chair, Institut de la Mémoire et de la Maladie d’Alzheimer (IM2A), Paris, France; Institut du Cerveau et de la Moelle épinière (ICM), Département de Neurologie, Hôpital de la Pitié-Salpétrière, Paris, France4 aut
700a Soininen, Hilkkau Institute of Clinical Medicine, Neurology, University of Eastern Finland, Kuopio, Finland; Neurocenter, Neurology, Kuopio University Hospital, Kuopio, Finland4 aut
700a Herukka, Sanna-Kaisau Institute of Clinical Medicine, Neurology, University of Eastern Finland, Kuopio, Finland; Neurocenter, Neurology, Kuopio University Hospital, Kuopio, Finland4 aut
700a Scheltens, Philipu Alzheimer Center & Department of Neurology, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, Netherlands,Amsterdam UMC - Vrije Universiteit Amsterdam4 aut
700a Verhey, Frans R.u Department of Psychiatry and Neuropsychology, Maastricht University, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht, Netherlands4 aut
700a Visser, Pieter Jelleu Department of Psychiatry and Neuropsychology, Maastricht University, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht, Netherlands; Alzheimer Center & Department of Neurology, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, Netherlands,Amsterdam UMC - Vrije Universiteit Amsterdam4 aut
700a Alzheimer's Disease Neuroimaging Initiative, the4 ctb
710a Department of Psychiatry and Neuropsychology, Maastricht University, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht, Netherlandsb Department of Geriatric Psychiatry, Zentralinstitut für Seelische Gesundheit, University of Heidelberg, Mannheim, Germany4 org
773t Neurobiology of Agingd : Elsevierg 56, s. 33-40q 56<33-40x 0197-4580x 1558-1497
856u https://repository.uantwerpen.be/docman/irua/dca110/143153_2018_05_24.pdf
856u http://dx.doi.org/10.1016/j.neurobiolaging.2017.03.034y FULLTEXT
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-74047
8564 8u https://doi.org/10.1016/j.neurobiolaging.2017.03.034
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:136232937
8564 8u https://lup.lub.lu.se/record/f9eda6d8-d679-4d81-b560-6c3801a70540
8564 8u https://gup.ub.gu.se/publication/254306

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy